Sudden cardiac death in a young boy with multisystemic inflammatory syndrome in children (MISC)

Gurudutta Avathi Venkatesha1, Nidhi Srinivas1, Saril Mohamedali2

  • 1Paediatric Department, Rangadore Memorial Hospital, Bangalore, Karnataka, India.

BMJ Case Reports
|August 20, 2021
PubMed

Insights

Sudden cardiac death occurred in a child with multisystemic inflammatory syndrome in children (MISC) after initial recovery. This highlights the risk of fatal cardiac events during follow-up for MISC patients.

Area of Science:

  • Pediatric Cardiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Multisystemic inflammatory syndrome in children (MISC) temporally associated with SARS-CoV-2 is a serious condition.
  • Cardiovascular complications are a known cause of mortality during the acute phase of MISC.

Observation:

  • A previously healthy 12-year-old boy with MISC presented with cardiogenic shock and multiple organ dysfunction syndrome.
  • After initial improvement with intravenous immunoglobulin and steroids, the child experienced sudden cardiac arrest and died.
  • No reversible cause was identified during resuscitation efforts.

Findings:

  • Despite apparent recovery of myocardial function, cytokine-induced inflammation may render the myocardium arrhythmogenic.
  • This case represents the first reported instance of sudden cardiac death in a child with MISC days after critical illness recovery.
  • The risk of fatal outcomes persists during follow-up, even without coronary aneurysms.

Implications:

  • This case underscores the potential for delayed fatal cardiovascular events in children with MISC.
  • Further research is needed to identify clinical predictors of high-risk children with MISC.
  • Close monitoring and long-term follow-up are crucial for understanding and managing MISC sequelae.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
49
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
84
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
134
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
154
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
99
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
33